Literature DB >> 16522516

Lessons learnt from structural studies of the oestrogen receptor.

Ashley C W Pike1.   

Abstract

Over the last 10 years, structural studies of the ligand-binding domains of nuclear hormone receptors have provided a wealth of information on the nature of ligand-binding and its role in receptor activation. This review examines the insights that studies on oestrogen receptor subtypes ERalpha and ERbeta have provided in terms of (1) basis of receptor activation; (2) recruitment of coregulators; (3) hormone recognition; and (4) subtype-selective ligands. It also highlights the implications for the binding of endocrine disruptors.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16522516     DOI: 10.1016/j.beem.2005.09.002

Source DB:  PubMed          Journal:  Best Pract Res Clin Endocrinol Metab        ISSN: 1521-690X            Impact factor:   4.690


  33 in total

Review 1.  Hormone action in the mammary gland.

Authors:  Cathrin Brisken; Bert O'Malley
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-08-25       Impact factor: 10.005

2.  Research resource: Transcriptional profiling in a cellular model of breast cancer reveals functional and mechanistic differences between clinically relevant SERM and between SERM/estrogen complexes.

Authors:  Suzanne E Wardell; Dmitri Kazmin; Donald P McDonnell
Journal:  Mol Endocrinol       Date:  2012-05-08

Review 3.  A structural view of nuclear hormone receptor: endocrine disruptor interactions.

Authors:  Albane le Maire; William Bourguet; Patrick Balaguer
Journal:  Cell Mol Life Sci       Date:  2010-01-09       Impact factor: 9.261

4.  A new fluorescence complementation biosensor for detection of estrogenic compounds.

Authors:  Michael J McLachlan; John A Katzenellenbogen; Huimin Zhao
Journal:  Biotechnol Bioeng       Date:  2011-08-04       Impact factor: 4.530

Review 5.  Small molecule modulation of nuclear receptor conformational dynamics: implications for function and drug discovery.

Authors:  Douglas J Kojetin; Thomas P Burris
Journal:  Mol Pharmacol       Date:  2012-08-06       Impact factor: 4.436

Review 6.  Potential approaches to enhance the effects of estrogen on senescent blood vessels and postmenopausal cardiovascular disease.

Authors:  Raouf A Khalil
Journal:  Cardiovasc Hematol Agents Med Chem       Date:  2010-01

7.  The role of activation functions 1 and 2 of estrogen receptor-α for the effects of estradiol and selective estrogen receptor modulators in male mice.

Authors:  Anna E Börjesson; Helen H Farman; Cecilia Engdahl; Antti Koskela; Klara Sjögren; Jenny M Kindblom; Alexandra Stubelius; Ulrika Islander; Hans Carlsten; Maria Cristina Antal; Andrée Krust; Pierre Chambon; Juha Tuukkanen; Marie K Lagerquist; Sara H Windahl; Claes Ohlsson
Journal:  J Bone Miner Res       Date:  2013-05       Impact factor: 6.741

Review 8.  Estrogenic compounds, estrogen receptors and vascular cell signaling in the aging blood vessels.

Authors:  Dia A Smiley; Raouf A Khalil
Journal:  Curr Med Chem       Date:  2009       Impact factor: 4.530

9.  Lasofoxifene: Evidence of its therapeutic value in osteoporosis.

Authors:  Luigi Gennari; Daniela Merlotti; Vincenzo De Paola; Ranuccio Nuti
Journal:  Core Evid       Date:  2010-06-15

10.  Novel Selective Estrogen Receptor Ligand Conjugates Incorporating Endoxifen-Combretastatin and Cyclofenil-Combretastatin Hybrid Scaffolds: Synthesis and Biochemical Evaluation.

Authors:  Patrick M Kelly; Niall O Keely; Sandra A Bright; Bassem Yassin; Gloria Ana; Darren Fayne; Daniela M Zisterer; Mary J Meegan
Journal:  Molecules       Date:  2017-08-31       Impact factor: 4.411

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.